COVID-19 y Psoriasis
COVID-19 y Psoriasis Peter van de Kerkhof, MD, PhD | Netherlands 2021
Saturday, April 17, 2021
Resource Tag: COVID-19
Genetic Studies Suggest That Inflammatory Skin Diseases Increase the Risk of COVID-19
An article recently published in the Journal of Allergy and Clinical Immunology suggests that diseases such as psoriasis and atopic
Monday, February 8, 2021
NPF COVID-19 Task Force Guidance Statements
Recently, the Task Force (TF) of the National Psoriasis Foundation (NPF) released a revised version of its COVID-19 statement after
Wednesday, January 6, 2021
Management of Psoriasis with Biologics during the COVID-19 Pandemic
Management of Psoriasis with Biologics During COVID Pandemic Paolo Gisondi, MD | Italy2020https://youtu.be/sl28UvbuKqY
Tuesday, December 8, 2020
Gestione della psoriasi con farmaci biologici durante la pandemia COVID
Management of Psoriasis with Biologics During COVID Pandemic – Italian Paolo Gisondi, MD | Italy2020https://www.youtube.com/watch?v=epK8HYRyTFI
Tuesday, December 8, 2020
Factors Associated with Adverse COVID-19 Outcomes in Patients with Psoriasis – Insights from A Global Registry-based Study
Commentary provided on this international moderate-severe psoriasis case series, where biologics use was associated with lower risk of COVID-19-related hospitalization
Friday, October 23, 2020
National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease
IPC Founding President Alan Menter and IPC Councilor Ulrich Mrowietz discuss the new guidance on psoriasis care from the National
Tuesday, October 6, 2020
